Celldex Therapeutics Inc.

NASDAQ: CLDX · Real-Time Price · USD
25.08
0.14 (0.56%)
At close: Aug 15, 2025, 12:49 PM

Celldex Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-157.86M -141.43M -112.33M -70.51M
Depreciation & Amortization
-12.57M 3.01M 2.9M 3.07M
Stock-Based Compensation
34.24M 23.89M 15.61M 8.95M
Other Working Capital
-35.16M 6.36M -6.85M -6.28M
Other Non-Cash Items
16K -6.22M -5.79M -1.14M
Deferred Income Tax
n/a n/a -227K -227K
Change in Working Capital
-21.6M 13.46M -3.9M -1.05M
Operating Cash Flow
-157.78M -107.29M -103.73M -60.91M
Capital Expenditures
-1.92M -1.82M -1.83M -1.25M
Cash Acquisitions
n/a n/a 69K 27K
Purchase of Investments
-789.92M -424.56M -188.97M -389.88M
Sales Maturities Of Investments
501.71M 320.6M 280.67M 174.95M
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-290.13M -105.78M 89.94M -216.16M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a 2.48M
Financial Cash Flow
441.45M 218.46M 4.08M 272.37M
Net Cash Flow
-6.46M 5.38M -9.71M -4.69M
Free Cash Flow
-159.7M -109.11M -105.56M -62.16M